創薬インフォマティクスの市場規模、シェア、動向分析レポート：サービス別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

創薬インフォマティクス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の創薬インフォマティクス市場規模は、2025年から2030年にかけて11.6%のCAGRを記録し、2030年までに70億3,000万米ドルに達する見込みです。

迅速な薬剤設計・合成、疾患進展の効率的な追跡、データの完全性管理など、いくつかの利点があるため、市場情報を得るために創薬ソフトウェアを使用することが、近年研究者の間で大幅に増加し、業界の成長を牽引しています。

新規分子に対する需要の高まりは、標的高分子の相互作用を通じて合理的な薬剤分子を同定することで、創薬プロセス全体のスピードアップを目指すインフォマティクス・ソリューションの採用を後押ししています。同市場で事業を展開する企業は、創薬プラットフォームの拡大のために資金援助を受けており、市場の成長をさらに後押ししています。例えば、2020年9月、アルディジェンは国立研究開発センターと契約を締結し、新規技術開発のための資金提供を受けた。

この技術は、免疫腫瘍学のためのT細胞受容体に基づく治療法の開発に革命を起こすことを目的としていました。アルディジェンはこれまでに、ネオアンチゲン予測プラットフォームArdImmune Vaxを開発しており、養子細胞療法やがんワクチンの標的として最適なネオアンチゲンを同定するために、すぐに使える人工知能（AI）とバイオインフォマティクス・ソリューションを展開しています。加えて、ケミカル・インフォマティクス・ソリューションは、特に最近のCOVID-19パンデミックに関連したニーズに対応する上で、この1年で大きな支持を得た。

例えば、2021年1月に行われた調査では、SARS-CoV-2 Mpro阻害剤の探索を加速するために、SARS-CoVメインプロテアーゼ（Mpro）阻害剤の過去の活性データのデータ解析による化学デジタルソリューションの応用が紹介されました。さらにQSARモデルは、迅速なCOVID-19創薬のための分子のデータマイニングに役立ちました。したがって、COVID-19の医薬品開発を促進する必要性が、今後数年間の業界拡大を促進すると予想されます。

創薬インフォマティクス市場レポートハイライト

• シーケンス分析プラットフォームが市場を独占し、2024年には36.4%の最大収益シェアを占める。バイオインフォマティクスソリューションは、核酸、タンパク質、その他の生体分子配列の一次および二次データベースの開発に広く採用されています。
• 創薬インフォマティクス部門は、2024年に約60.2%の最大の売上シェアを占め、精密医薬品の開発に大きな焦点を当てています。精密医療は、個人の遺伝的・分子的プロファイルに合わせた個別化医療の提供を中心に展開されています。
• 市場では製薬・バイオテクノロジー企業が圧倒的な地位を占め、2024年の収益シェアは48.4%で最大となりました。この成長は、特に精密医療における研究開発費の増加に起因しています。
• 北米は、主要市場プレイヤーの存在と確立された研究開発インフラにより、2024年の世界市場をリードしました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 創薬インフォマティクス市場の変数、動向、範囲

• 市場系統の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ビジネス環境分析
  • 業界分析- ポーターのファイブフォース分析
  • PESTLE分析

第4章 創薬インフォマティクス市場：サービス別事業分析

• サービス別市場シェア、2024年と2030年
• サービス別セグメントダッシュボード
• 市場規模、予測、動向分析（サービス別、2018～2030年）
• 配列解析プラットフォーム
• 分子モデリング
• ドッキング
• 臨床試験データ管理
• その他

第5章 創薬インフォマティクス市場：用途別ビジネス分析

• 用途別市場シェア、2024年および2030年
• 用途別セグメントダッシュボード
• 市場規模、予測、動向分析（用途別、2018～2030年）
• 創薬インフォマティクス
• バイオコンテンツ管理

第6章 創薬インフォマティクス市場：エンドユーザー別ビジネス分析

• 最終用途別市場シェア、2024年および2030年
• 最終用途別セグメントダッシュボード
• 市場規模、予測、動向分析（最終用途別、2018～2030年）
• 製薬・バイオテクノロジー企業
• CROとCMO
• 学術研究機関

第7章 創薬インフォマティクス市場：地域別推定・動向分析

• 地域別市場シェア分析、2024年および2030年
• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018年から2030年まで：
• 北米
  • 国別、2018年～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 国別、2018年～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 国別、2018年～2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • 国別、2018年～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 国別、2018年～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参加者概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/リスト
  • Certara
  • Boehringer Ingelheim International GmbH
  • Infosys Ltd.
  • Charles River Laboratories
  • Collaborative Drug Discovery, Inc.
  • Eurofins DiscoverX Products
  • Jubliant Biosys
  • Selvita
  • Novo Informatics Pvt. Ltd.
  • ChemAxon Ltd.
  • Albany Molecular Research Inc.
  • Oracle
  • Accenture
  • Agilent Technologies, Inc.
  • Illumina, Inc.

List of Tables

• Table 1. List Of Secondary Sources
• Table 2. List Of Abbreviations
• Table 3. Global Drug Discovery Informatics Market, By Region, 2018 - 2030 (USD Million)
• Table 4. Global Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 5. Global Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 6. Global Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 7. North America Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
• Table 8. North America Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 9. North America Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 10. North America Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 11. U.S. Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 12. U.S. Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 13. U.S. Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 14. Canada Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 15. Canada Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 16. Canada Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 17. Mexico Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 18. Mexico Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 19. Mexico Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 20. Europe Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
• Table 21. Europe Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 22. Europe Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 23. Europe Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 24. UK Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 25. UK Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 26. UK Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 27. Germany Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 28. Germany Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 29. Germany Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 30. France Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 31. France Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 32. France Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 33. Italy Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 34. Italy Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 35. Italy Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 36. Spain Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 37. Spain Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 38. Spain Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 39. Denmark Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 40. Denmark Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 41. Denmark Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 42. Sweden Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 43. Sweden Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 44. Sweden Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 45. Norway Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 46. Norway Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 47. Norway Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 48. Asia Pacific Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
• Table 49. Asia Pacific Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 50. Asia Pacific Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 51. Asia Pacific Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 52. Japan Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 53. Japan Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 54. Japan Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 55. China Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 56. China Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 57. China Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 58. India Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 59. India Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 60. India Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 61. Australia Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 62. Australia Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 63. Australia Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 64. Thailand Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 65. Thailand Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 66. Thailand Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 67. South Korea Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 68. South Korea Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 69. South Korea Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 70. Latin America Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
• Table 71. Latin America Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 72. Latin America Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 73. Latin America Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 74. Brazil Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 75. Brazil Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 76. Brazil Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 77. Argentina Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 78. Argentina Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 79. Argentina Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 80. Middle East & Africa Drug Discovery Informatics Market, By Country, 2018 - 2030 (USD Million)
• Table 81. Middle East & Africa Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 82. Middle East & Africa Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 83. Middle East & Africa Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 84. South Africa Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 85. South Africa Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 86. South Africa Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 87. Saudi Arabia Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 88. Saudi Arabia Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 89. Saudi Arabia Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 90. UAE Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 91. UAE Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 92. UAE Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)
• Table 93. Kuwait Drug Discovery Informatics Market, By Service, 2018 - 2030 (USD Million)
• Table 94. Kuwait Drug Discovery Informatics Market, By Application, 2018 - 2030 (USD Million)
• Table 95. Kuwait Drug Discovery Informatics Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Drug Discovery Informatics Market Segmentation
• Fig. 2 Market Research Process
• Fig. 3 Data Triangulation Techniques
• Fig. 4 Primary Research Pattern
• Fig. 5 Market Research Approaches
• Fig. 6 Value-Chain-Based Sizing & Forecasting
• Fig. 7 Market Formulation & Validation
• Fig. 8 Market Snapshot
• Fig. 9 Service and Application Outlook (USD Million)
• Fig. 10 End Use Outlook (USD Million)
• Fig. 11 Competitive Landscape
• Fig. 12 Drug Discovery Informatics Market Dynamics
• Fig. 13 Drug Discovery Informatics Market: Porter's Five Forces Analysis
• Fig. 14 Drug Discovery Informatics Market: PESTLE Analysis
• Fig. 15 Drug Discovery Informatics Market: Service Segment Dashboard
• Fig. 16 Drug Discovery Informatics Market: Service Market Share Analysis, 2024 & 2030
• Fig. 17 Sequence Analysis Platforms Market, 2018 - 2030 (USD Million)
• Fig. 18 Molecular Modelling Market, 2018 - 2030 (USD Million)
• Fig. 19 Docking Market, 2018 - 2030 (USD Million)
• Fig. 20 Clinical Trial Data Management Market, 2018 - 2030 (USD Million)
• Fig. 21 Others Market, 2018 - 2030 (USD Million)
• Fig. 22 Drug Discovery Informatics Market: Application Segment Dashboard
• Fig. 23 Drug Discovery Informatics Market: Application Market Share Analysis, 2024 & 2030
• Fig. 24 Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 25 Biocontent Management Market, 2018 - 2030 (USD Million)
• Fig. 26 Drug Discovery Informatics Market: End Use Segment Dashboard
• Fig. 27 Drug Discovery Informatics Market: End Use Market Share Analysis, 2024 & 2030
• Fig. 28 Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
• Fig. 29 CROs & CMOs Market, 2018 - 2030 (USD Million)
• Fig. 30 Academic & Research Institutes Market, 2018 - 2030 (USD Million)
• Fig. 31 Drug Discovery Informatics Market Revenue, By Region
• Fig. 32 Regional Marketplace: Key Takeaways
• Fig. 33 Regional Marketplace: Key Takeaways
• Fig. 34 North America Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 35 U.S. Country Dynamics
• Fig. 36 U.S. Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 37 Canada Country Dynamics
• Fig. 38 Canada Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 39 Mexico Country Dynamics
• Fig. 40 Mexico Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 41 Europe Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 42 UK Country Dynamics
• Fig. 43 UK Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 44 Germany Country Dynamics
• Fig. 45 Germany Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 46 France Country Dynamics
• Fig. 47 France Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 48 Italy Country Dynamics
• Fig. 49 Italy Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 50 Spain Country Dynamics
• Fig. 51 Spain Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 52 Norway Country Dynamics
• Fig. 53 Norway Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 54 Sweden Country Dynamics
• Fig. 55 Sweden Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 56 Denmark Country Dynamics
• Fig. 57 Denmark Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 58 Asia Pacific Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 59 Japan Country Dynamics
• Fig. 60 Japan Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 61 China Country Dynamics
• Fig. 62 China Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 63 India Country Dynamics
• Fig. 64 India Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 65 Australia Country Dynamics
• Fig. 66 Australia Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 67 Thailand Country Dynamics
• Fig. 68 Thailand Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 69 South Korea Country Dynamics
• Fig. 70 South Korea Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 71 Latin America Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 72 Brazil Country Dynamics
• Fig. 73 Brazil Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 74 Argentina Country Dynamics
• Fig. 75 Argentina Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 76 MEA Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 77 South Africa Country Dynamics
• Fig. 78 South Africa Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 79 Saudi Arabia Country Dynamics
• Fig. 80 Saudi Arabia Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 81 UAE Country Dynamics
• Fig. 82 UAE Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 83 Kuwait Country Dynamics
• Fig. 84 Kuwait Drug Discovery Informatics Market, 2018 - 2030 (USD Million)
• Fig. 85 Company Categorization
• Fig. 86 Company Market Position Analysis
• Fig. 87 Strategic Framework

Drug Discovery Informatics Market Growth & Trends:

The global drug discovery informatics market size is expected to reach USD 7.03 billion by 2030, registering a CAGR of 11.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. Use of drug discovery software for gaining market intelligence owing to several advantages, such as rapid drug design & synthesis, efficient tracking of disease evolution, and data integrity management, has increased significantly among the researchers in the recent years, driving the industry growth.

The growing demand for novel molecules is driving the adoption of informatics solutions targeted towards speeding up the entire drug discovery process by identifying rational drug molecules via the target macromolecule interaction. Companies operating in the market are receiving funding for expanding their drug discovery platforms, further supplementing the market growth. For instance, in September 2020, Ardigen signed an agreement with the National Centre for Research and Development to access its funding for developing novel technology.

This technology was aimed at revolutionizing the development of T-cell receptors-based therapies for immuno-oncology. Ardigen has previously developed a neoantigen prediction platform namely, ArdImmune Vax, which deploys ready-to-use Artificial Intelligence (AI) and bioinformatics solutions for the identification of optimal sets of neoantigens as targets for adoptive cell therapies and cancer vaccines. In addition, chemical informatics solutions have gained considerable traction in the past year, particularly in addressing the needs associated with the recent Covid-19 pandemic.

For instance, a research study performed in January 2021 showcased the application of chemical digital solutions in accelerating the search of SARS-CoV-2 Mpro inhibitors by data analysis of previous activity data of SARS-CoV main protease (Mpro) inhibitors. In addition, the QSAR models helped in the data mining of molecules for rapid Covid-19 drug discovery. Hence, the need to facilitate drug development for Covid-19 is expected to propel the industry expansion over the coming years.

Drug Discovery Informatics Market Report Highlights:

• The sequence analysis platforms dominated the market and accounted for the largest revenue share of 36.4% in 2024. Bioinformatics solutions are widely employed for the development of primary and secondary databases of nucleic acids, proteins, and other biomolecule sequences.
• The discovery informatics segment accounted for the largest revenue share of around 60.2% in 2024, with a major focus on developing precision medicines. Precision medicine revolves around providing personalized medical care tailored to an individual's genetic and molecular profile.
• Pharmaceutical and biotechnology companies held the dominant position in the market, with the largest revenue share of 48.4% in 2024. This growth is attributed to increased R&D spending, particularly in precision medicine.
• North America led the global market in 2024 due to the presence of key market players and established R&D infrastructure in the country

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Drug Discovery Informatics Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Drug Discovery Informatics Market: Service Business Analysis

• 4.1. Service Market Share, 2024 & 2030
• 4.2. Service Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2018 to 2030 (USD Million)
• 4.4. Sequence Analysis Platforms
  • 4.4.1. Sequence Analysis Platforms Market, 2018 - 2030 (USD Million)
• 4.5. Molecular Modelling
  • 4.5.1. Molecular Modelling Market, 2018 - 2030 (USD Million)
• 4.6. Docking
  • 4.6.1. Docking Market, 2018 - 2030 (USD Million)
• 4.7. Clinical Trial Data Management
  • 4.7.1. Clinical Trial Data Management Market, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Drug Discovery Informatics Market: Application Business Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Discovery Informatics
  • 5.4.1. Discovery Informatics Market, 2018 - 2030 (USD Million)
• 5.5. Biocontent Management
  • 5.5.1. Biocontent Management Market, 2018 - 2030 (USD Million)

Chapter 6. Drug Discovery Informatics Market: End Use Business Analysis

• 6.1. End Use Market Share, 2024 & 2030
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Pharmaceutical & Biotechnology Companies
  • 6.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
• 6.5. CROs & CMOs
  • 6.5.1. CROs & CMOs Market, 2018 - 2030 (USD Million)
• 6.6. Academic & Research Institutes
  • 6.6.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)

Chapter 7. Drug Discovery Informatics Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Denmark Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Sweden Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Norway Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. Australia Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Thailand Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. South Korea
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. South Korea Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Drug Discovery Informatics Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Drug Discovery Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Certara
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Boehringer Ingelheim International GmbH
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Infosys Ltd.
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Charles River Laboratories
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. Collaborative Drug Discovery, Inc.
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Eurofins DiscoverX Products
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. Jubliant Biosys
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. Selvita
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. Novo Informatics Pvt. Ltd.
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic Initiatives
  • 8.5.10. ChemAxon Ltd.
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial Performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic Initiatives
  • 8.5.11. Albany Molecular Research Inc.
    • 8.5.11.1. Overview
    • 8.5.11.2. Financial Performance
    • 8.5.11.3. Product Benchmarking
    • 8.5.11.4. Strategic Initiatives
  • 8.5.12. Oracle
    • 8.5.12.1. Overview
    • 8.5.12.2. Financial Performance
    • 8.5.12.3. Product Benchmarking
    • 8.5.12.4. Strategic Initiatives
  • 8.5.13. Accenture
    • 8.5.13.1. Overview
    • 8.5.13.2. Financial Performance
    • 8.5.13.3. Product Benchmarking
    • 8.5.13.4. Strategic Initiatives
  • 8.5.14. Agilent Technologies, Inc.
    • 8.5.14.1. Overview
    • 8.5.14.2. Financial Performance
    • 8.5.14.3. Product Benchmarking
    • 8.5.14.4. Strategic Initiatives
  • 8.5.15. Illumina, Inc.
    • 8.5.15.1. Overview
    • 8.5.15.2. Financial Performance
    • 8.5.15.3. Product Benchmarking
    • 8.5.15.4. Strategic Initiatives